CNX
44
2
CVS
45
-2
VRSN
58
8
DLTR
54
2
WYNN
36
2
NTAP
52
3
AMG
52
-2
KMI
57
2
GILD
65
-3
KR
65
-3
HES
52
2
TDC
44
3
KO
55
-12
KLAC
67
2
FLS
64
3
LH
42
2
TXN
55
3
PWR
75
4
AVY
47
-4
TGNA
58
2
CNX
44
2
CVS
45
-2
VRSN
58
8
DLTR
54
2
WYNN
36
2
NTAP
52
3
AMG
52
-2
KMI
57
2
GILD
65
-3
KR
65
-3
HES
52
2
TDC
44
3
KO
55
-12
KLAC
67
2
FLS
64
3
LH
42
2
TXN
55
3
PWR
75
4
AVY
47
-4
TGNA
58
2
Financhill
Back

Blueprint Medicines Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

BPMC
Blueprint Medicines

Last Price:
$87.68
Seasonality Move:
7.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 29.4% based on the past 9 years of stock performance.
  • Blueprint Medicines has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $87.66. The Score for BPMC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 29.4% based on the past 9 years of stock performance.

Blueprint Medicines Stock Rating

Sell
45
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • The current trend is relatively stagnant and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
121.90
52-Week Low:
73.04

Prediction Charts

Market Cap:
5.6B
Price in USD:
87.66
Volume:
679.5K
Beta:
0.94

Technical Analysis

SMA50:
88.80
SMA100:
94.16
SMA200:
94.92
52-Wk Change:
-3.38%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 87.66 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 79.00 80.20 83.91 76.50
Apr-8 82.09 79.22 84.66 77.36
Apr-9 77.49 82.05 83.54 73.04
Apr-10 78.48 80.27 81.86 76.84
Apr-11 78.50 80.84 81.28 77.63
Apr-14 82.38 82.53 83.50 79.91
Apr-15 81.93 81.45 83.45 79.91
Apr-16 81.05 82.11 82.18 78.66
Apr-17 82.16 84.69 84.97 81.19
Apr-21 84.01 84.18 86.10 83.60
Apr-22 84.50 83.41 85.41 83.27
Apr-23 86.02 85.81 86.85 84.38
Apr-24 86.07 86.09 86.84 84.90
Apr-25 84.78 87.66 87.81 84.25

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.63 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.32 per share, and an increase next year of $2.76 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.